Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology

Pretherapy I-123 imaging in determination of the ablation dose of I-131 in post-surgical thyroid cancer patients

Damita Thomas, Yusuf Menda and David Bushnell
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 435;
Damita Thomas
1University of Iowa, Iowa City, IA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yusuf Menda
1University of Iowa, Iowa City, IA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Bushnell
1University of Iowa, Iowa City, IA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

435

Objectives To determine if pre-therapy I-123 imaging in postoperative thyroid cancer patients aid in the determination of the I-131 radioablative/treatment dosage.

Methods Histopathology reports and pretherapy I-123 images from 49 post-surgical thyroid cancer patients were retrospectively reviewed. To determine if I-123 pretherapy imaging impacts the determination of the I-131 dosage, dosages for each patient were first determined based on age, pathology and staging information. The treatment dosage was again determined after interpretation of the I-123 scan. A "fixed" dosage approach was used (100 mCi for remnant ablation, 150 mCi if cervical nodes visualized, 200 mCi if distant disease was present).

Results The I-131 dosage was unchanged in 39 patients (80%), changed in 10 patients (20%). Among the 39 concordant patients, the disease stage was I in 23, II in 5, III in 9 and IV in 2 patients. Among the 10 discordant patients, disease stage was I in 3 patients, II in 4, and III in 3. In the discordant group, the determined dosage was higher when pre-therapy imaging was used. Patients were also evaluated in terms of whether surgical nodal sampling was performed, which was done in 30/49 patients. When pre-therapy scans were used, the derived dosage was different in only 10% (3/30) of these patients. This compares to 37% (7/19) of patients in which nodal sampling was not performed.

Conclusions Pretherapy I-123 scans do not alter the I-131 therapeutic dosage in the majority of patients after thyroidectomy. The pretherapy scans appear to influence the dosage more frequently in patients without nodal staging at the time of surgery.

  • © 2009 by Society of Nuclear Medicine
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pretherapy I-123 imaging in determination of the ablation dose of I-131 in post-surgical thyroid cancer patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Pretherapy I-123 imaging in determination of the ablation dose of I-131 in post-surgical thyroid cancer patients
Damita Thomas, Yusuf Menda, David Bushnell
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 435;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pretherapy I-123 imaging in determination of the ablation dose of I-131 in post-surgical thyroid cancer patients
Damita Thomas, Yusuf Menda, David Bushnell
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 435;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology

  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
Show more General Clinical Specialties: Endocrinology

Updates in Hyperthyroidism

  • Serum TSH and the influence of statin drugs.
  • Thyroid status and autoantibodies in first degree relatives of children with autoimmune thyroiditis
Show more Updates in Hyperthyroidism

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire